biguanides has been researched along with Cancer of Pituitary in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vázquez-Borrego, MC | 1 |
Fuentes-Fayos, AC | 1 |
Herrera-Martínez, AD | 1 |
L-López, F | 1 |
Ibáñez-Costa, A | 1 |
Moreno-Moreno, P | 1 |
Alhambra-Expósito, MR | 1 |
Barrera-Martín, A | 1 |
Blanco-Acevedo, C | 1 |
Dios, E | 1 |
Venegas-Moreno, E | 1 |
Solivera, J | 1 |
Gahete, MD | 1 |
Soto-Moreno, A | 1 |
Gálvez-Moreno, MA | 1 |
Castaño, JP | 1 |
Luque, RM | 1 |
1 other study available for biguanides and Cancer of Pituitary
Article | Year |
---|---|
Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Biguanides; Cell Line, Tumor; Cell | 2019 |